Radiation and Cancer Physics

Panel 05 - NCI's Quantitative Imaging Network: Development and Integration of Novel Tools for Oncology Clinical Trials and Patient Management

Development of novel spectroscopic MRI technique for evaluation and followup of brain tumors

Monday, October 22
11:45 AM - 12:05 PM
Location: Lila Cockrell Theatre

Hui-Kuo George Shu, MD, PhD, FASTRO

Winship Cancer Institute of Emory University

Disclosure:
Employment
Emory University, Dept. of Radiation Oncology: Professor: Employee

Compensation
Varian Medical Systems: Honoraria, Speaker's Bureau, Travel Expenses

Ownership
Apple: Stock; Medtronics: Stock

Leadership
NCI-QIRT Working Group: Co-Chairman; QIN CTTDWG: Chairman; QIN EC: Co-Chairman

Biography:
Hui-Kuo G. Shu, MD, PhD, is a professor in the Department of Radiation Oncology at Emory University. He received his BA in biology at Washington University in St. Louis, MO, in 1986 and MD/PhD in molecular biology at Case Western Reserve University in Cleveland, OH, in 1993. He completed of an internship in Internal Medicine at University Hospitals of Cleveland in 1994 and residency in Radiation Oncology at the University of California, San Francisco in 1999. He also completed a two year research fellowship at the Brain Tumor Research Center at UCSF. He has been a member of the Department of Radiation Oncology at Emory University since 2005.
Dr. Shu specializes in the treatment of CNS malignancies with radiation and has published extensively in these areas. He is actively involved many brain tumor clinical trials including as PI for investigator-initiated trials examining a novel histone deacetylase inhibitor for glioblastoma therapy and innovative use of volumetric modulated arc therapy for treatment of brain metastasis. Overall, he has published, as lead/senior author or co-author, more than 80 peer-reviewed manuscripts and 120 abstracts presented at national or international meetings. His most recent research interests have been in the development of spectroscopic magnetic resonance imaging (sMRI) for evaluating glioblastomas particularly focusing on its use to better guide radiation treatment planning for infiltrative disease not otherwise appreciated on standard MRI sequences. He is co-PI of the Emory Brain Tumor Imaging team that is funded by the National Institutes of Health (NIH) to develop sMRI for glioblastoma imaging as one of approximately 25 teams that make up the National Cancer Institute’s Quantitative Imaging Network (QIN). He is active in many professional/scientific societies including the American Society for Therapeutic Radiology and Oncology (ASTRO), the Radiological Society of North America (RSNA), the Society for Neuro-Oncology (SNO), among others.

Presentation(s):

Send Email for Hui-Kuo George Shu


Assets

Development of novel spectroscopic MRI technique for evaluation and followup of brain tumors



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Development of novel spectroscopic MRI technique for evaluation and followup of brain tumors